Other languages COSMOS Pharmaceutical Corporation

Equities

3349

JP3298400007

Delayed Japan Exchange Other stock markets 02:00:00 2024-07-03 EDT			5-day change	1st Jan Change
13,105 ^JPY	+0.77%		-0.57%	-19.53%

04-12	Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	MT
04-12	COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	CI

Other languages

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Cosmos Pharmaceutical's Attributable Profit Up 6.6% in Fiscal Nine Months	04-12
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal Year Ending May 31, 2024	04-12
Cosmos Pharmaceutical’s Attributable Profit Up 2.6% in Fiscal H1 on Expansion of Stores	01-12
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2024	01-12
COSMOS Pharmaceutical Corporation Announces Dividend for the Second Quarter End of Fiscal Year Ending May 31, 2024, Payable on February 13, 2024; Provides Year Dividend Guidance for fiscal Year Ending May 31, 2024	01-12
Criptomonedas: Tres temáticas a tener en cuenta	12-21
Cosmos Pharmaceutical’s Attributable Profit up marginally by 0.4% in Fiscal Q1 After Opening New Stores	23-10-12
COSMOS Pharmaceutical Corporation Reports Earnings Results for the First Quarter Ended August 31, 2023	23-10-11
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	23-10-11
OPINIONES DE LOS ANALISTAS DEL DÍA : Santander, Demant, Lufthansa, AXA, BAE Systems, Adidas, GSK, Demant, Just Eat...	23-08-08
Revenez, la semaine n'est pas finie !	23-08-08
AVIS D'ANALYSTES DU JOUR : Saint-Gobain, AXA, Crédit Agricole, Adidas, Demant, Ipsen, Just Eat...	23-08-08
Cosmos Attributable Profit Increases 2.8% in Fiscal Year 2023	23-07-10
COSMOS Pharmaceutical Corporation Announces Year-End Dividend for the Year Ended May 31, 2023, Payable on August 3, 2023; Provides Dividend Guidance for the Second Quarter-End and Full Year of Full Year Ending May 31, 2024	23-07-10
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the First Half and Full Year of Fiscal Year Ending May 31, 2024	23-07-10
Cosmos Pharma's Attributable Profit Slides 1% in Fiscal Nine Months Amid New Store Openings	23-04-11
COSMOS Pharmaceutical Corporation Provides Consolidated Earnings Guidance for the Fiscal Year Ending May 31, 2023	23-04-10
COSMOS Pharmaceutical Corporation Provides Dividend Guidance for the Fiscal year ending May 31, 2023	23-04-10
AVIS D'ANALYSTES DU JOUR : Airbus, Thales, STMicroelectronics, FDJ, Ubisoft, TF1, Ferrari, Cosmo...	23-01-31
Cosmos Pharma Books Marginal Rise in Fiscal H1 Attributable Profit Amid New Store Openings, Low-cost Strategy	23-01-15

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Other languages COSMOS Pharmaceutical Corporation

Equities

3349

JP3298400007

Other languages

Filters